Merck has sued the US over a law that hands the federal government the power to negotiate prices for some of the most expensive drugs, arguing that key parts of the legislation are unconstitutional and “tantamount to extortion”.
The US drugmaker on Tuesday said the reforms contained in the Inflation Reduction Act, a key part of President Joe Biden’s agenda to reduce the cost of prescription medicines, violated the first and fifth amendments to the US constitution.
“This is not ‘negotiation’. It is tantamount to extortion. And it violates the constitution in at least two obvious respects,” said Merck in a court filing.
您已閱讀15%（623字），剩余85%（3643字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。